PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
J Immunol. Author manuscript; available in PMC 2010 July 15.
Published in final edited form as:
PMCID: PMC2735238
NIHMSID: NIHMS116656

Autocrine IL-10 induces hallmarks of alternative activation in macrophages and suppresses anti-tuberculosis effector mechanisms without compromising T cell immunity1

Abstract

Elevated IL-10 has been implicated in reactivation tuberculosis (TB). Since macrophages rather than T cells were reported to be the major source of IL-10 in TB, we analyzed the consequences of a macrophage-specific overexpression of IL-10 in transgenic mice (macIL-10-transgenic) after aerosol infection with Mycobacterium tuberculosis (Mtb). MacIL-10-transgenic mice were more susceptible to chronic Mtb infection than non-transgenic littermates, exhibiting higher bacterial loads in the lung after 12 weeks of infection and dying significantly earlier than controls. The differentiation, recruitment and activation of TH1 cells as well as the induction of IFN-gamma-dependent effector genes against Mtb were not affected by macrophage-derived IL-10. However, microarray analysis of pulmonary gene expression revealed patterns characteristic of alternative macrophage activation that were overrepresented in Mtb-infected macIL-10-transgenic mice. Importantly, arginase-1 gene expression and activity were strikingly enhanced in transgenic mice accompanied by a reduced production of reactive nitrogen intermediates. Moreover, IL-10-dependent arginase-1 induction diminished anti-mycobacterial effector mechanisms in macrophages. Together, macrophage-derived IL-10 triggers aspects of alternative macrophage activation and promotes Mtb recrudescence independent of overt effects on anti-TB T cell immunity.

Keywords: bacterial infection, cytokines, monocytes/macrophages, rodent

Introduction

Tuberculosis (TB) is one of the most prevalent bacterial infections world-wide and constitutes a leading global health threat (1). Human TB caused by Mycobacterium tuberculosis (Mtb) is responsible for 8 million new cases and nearly 2 million deaths annually. Primary TB is thought to depend on a combination of genetic susceptibility of the host and virulence of the infecting Mtb strain, whereas post-primary TB is due to a temporal dysregulation of otherwise intact immune defenses. More detailed elucidation of the balance between protective and inflammatory immune responses to Mtb may accelerate the development of more effective vaccines and therapies targeting both or either form of TB.

The cell-mediated immune response is known to be critical in the host defence against infection with intracellular pathogens such as mycobacteria. T helper 1 (TH1) lymphocytes play an important role in granuloma formation by secreting type 1 cytokines, primarily interferon-gamma (IFNγ) and tumour-necrosis-factor (TNF) (2, 3). These cytokines stimulate the anti-microbial activity of infected macrophages, allowing intracellular bacterial killing through reactive nitrogen intermediates (RNI) and LRG-47 (4, 5). Interleukin (IL)-12 indirectly promotes an effective cell-mediated immune response by inducing IFNγ production from T and NK cells. On the other hand, these protective T cell-mediated immune responses also play a causative role in the development of the pathology of this type of chronic disease (6). Hence, down-regulation of the inflammatory response by endogenous factors that limit tissue damage, can promote establishment of chronic infection and may also lead to reactivating TB. In fact, increased levels of TH2-type anti-inflammatory cytokines such as IL-4 and IL-10 were detected in patients suffering from post-primary disease (7).

IL-10 is produced by macrophages, T cells, B cells, and a variety of other cell types. The effects of IL-10 on immune responses are mostly inhibitory (8). In macrophages, IL-10 inhibits anti-microbial effector mechansims, the expression of co-stimulatory molecules and the production of proinflammatory cytokines (9, 10). Inhibition of IL-12 production by IL-10 (11) may be one mechanism by which IL-10 blocks the development of protective TH1 immune responses (12). The absence of IL-10 causes overproduction of inflammatory cytokines (13) and the development of chronic inflammatory bowel disease (14). On the other hand, IL-10-deficient (−/−) mice also show increased resistance to intracellular pathogens such as Listeria monocytogenes (15), Leishmania major (16), and Trypanosoma cruzi (17). Therefore, IL-10 is required to prevent immunopathology, but it can also impair protective responses against several pathogens. The immunoregulatory function of IL-10 and the fact that elevated levels of IL-10 have been detected in TB patients (18, 19) suggest a role for IL-10 in susceptibility to TB. However, one report of Mtb infection in IL-10−/− mice found neither increased protective immune responses nor in exacerbated immunopathology (20).

By contrast, mice lacking IL-10 were shown to clear M. bovis BCG infection more efficiently (21). Taken together, further investigation of Mtb infection in different IL-10 genetic models differing in the level or source of IL-10 production appear warranted. Indeed, mice overexpressing IL-10 in activated T cells (tIL-10tg mice) were previously reported to be more susceptible to Mtb infection, exhibiting an impaired TH1 development as characterized by decreased numbers of activated T cells in the blood circulation and lung tissue (22). Similarly, another T cell specific IL-10 transgenic model was also shown to have an increased M. bovis BCG burden (23). However, because IL-10 is only overexpressed in these mice when T cells become activated, effects of overproduction of IL-10 by innate immune cells could not be studied.

We were interested in analyzing the consequences of a macrophage-specific overexpression of IL-10 during experimental TB for the following reasons: first, macrophages rather than T cells were reported to be the major source of IL-10 in TB patients (18) and second, reactivation disease in patients is typically associated with a strong, rather than diminished, TH1 immune response (24). In this study, infection of mice expressing an epitope-tagged IL-10 under control of the human CD68 promoter specifically in macrophages (macIL-10tg mice) (25) resulted in a very different immunological phenotype than reported for Mtb-infected tIL-10tg mice. Even though macIL-10tg mice were also more susceptible to Mtb infection than non-transgenic littermates, the differentiation, recruitment and activation of TH1 cells as well as the induction of IFNγ-dependent effector genes against Mtb were unaffected by macrophage-derived IL-10. Transcriptome analysis revealed that after Mtb infection genes preferentially expressed in macrophages were specifically modulated in the lungs of macIL-10tg mice. Among these, genes typical for alternative macrophage activation, such as Arg1, were significantly induced in the lung transcriptome of Mtb-infected macIL-10tg mice. Together, our study revealed that macrophage-derived IL-10 induces alternatively activated macrophages and promotes exacerbation of chronic Mtb infection in the face of intact T cell immunity.

Materials and Methods

Mice and macrophages

Transgenic mice (macIL-10tg mice) specifically expressing IL-10 in macrophages under control of the human CD68 promoter were bred under specific-pathogen-free conditions at the Technical University of Munich (25). macIL-10tg mice were on a FVB genetic background and transgene-negative littermates were used as controls (FVB). Myeolid-specific arginase-1-deficient Tie2cre Arg-1flox/flox mice were housed at St. Jude Children's Research Hospital (26). In any given experiment, mice were matched for age and sex. For experiments, mice were maintained under barrier conditions in the BSL 3 facility at the Research Center Borstel in individually ventilated cages. All experiments performed were in accordance with the German Animal Protection Law and were approved by the Animal Research Ethics Board of the Ministry of Environment, Kiel, Germany.

Bone-marrow-derived macrophages (BMMAn external file that holds a picture, illustration, etc.
Object name is nihms-116656-ig0001.jpg) were obtained after flushing of femora from Tie2cre-pos Arg-1flox/flox mice and cre-negative littermates. To generate BMMAn external file that holds a picture, illustration, etc.
Object name is nihms-116656-ig0002.jpg, bone marrow cells were cultivated in L-929 conditioned medium as source for M-CSF activity for 9 days (27).

Bacteria and infection

Mtb (H37Rv) and M. avium (TMC724; originally obtained from Dr. F. Collins, Trudeau Institute, Saranac Lake, NY) were grown in Middlebrook 7H9 broth (Difco, Detroit, MI) supplemented with Middlebrook OADC enrichment medium (Life Technologies, Gaithersburg, MI), 0.002 % glycerol, and 0.05 % Tween 80. Midlog phase cultures were harvested, aliquoted, and frozen at −80°C. After thawing, viable cell counts were determined by plating serial dilutions of the cultures on Middlebrook 7H10 agar plates followed by incubation at 37°C. All experiments were performed in the BSL 3 laboratories at the Research Center Borstel. Before infection of experimental animals, stock solutions of mycobacteria were diluted in sterile distilled water and pulmonary infection was performed using an inhalation exposure system (Glas-Col, Terre-Haute, IN). To infect mice with 100 CFU Mtb or 105 M. avium per lung, animals were exposed for 40 min to an aerosol generated by nebulizing approximately 5.5 ml of a suspension containing 2 × 105 or 1 × 109 live bacteria per ml, respectively. Inoculum size was checked 24 h after infection by determining the bacterial load in the lung of infected mice. Mice were regularly weighed before and after infection. In accordance with the Animal Research Ethics Board of the Ministry of Environment, mice that lost 25% of their original weight during the course of infection had to be sacrificed.

Colony enumeration assays

Bacterial loads in lung, liver and spleen were evaluated at different time points after infection with mycobacteria to follow the course of infection. Organs from sacrificed animals were removed aseptically, weighed and homogenised in PBS containing a proteinase inhibitor cocktail (Roche Diagnostics, Mannheim, Germany) for subsequent quantification of cytokines prepared according to the manufacturer's instructions. Tenfold serial dilutions of organ homogenates were plated in duplicates onto Middlebrook 7H10 agar plates containing 10 % OADC and incubated at 37°C for 19−21 days. Colonies on plates were enumerated and results expressed as log10 CFU per organ.

Immunohistology

One lung lobe per mouse was fixed in 4% formalin-PBS, set in paraffin blocks, and sectioned (2−3 μm). For immunohistological detection of NOS2, tissue sections were deparaffinized, placed in 10 mm sodium citrate buffer (pH 6·0) and then pressure-cooked for exactly 1 min. After blocking for 20 min in 1% H2O2 solution, slides were incubated with appropriately diluted polyclonal rabbit anti-mouse inducible nitric oxide synthase (NOS2) (Biomol, Hamburg, Germany) in Tris-buffered saline (TBS) /10% fetal calf serum (FCS), for 30 min in a humid chamber. Appropriately diluted goat anti-rabbit immunoglobulin G (IgG) (bridging antibody) (Dianova, Hamburg, Germany) and diluted rabbit anti-goat IgG-peroxidase conjugate (tertiary antibody) (Dianova) were used in sequential incubations of 30 min each. For immunohistological detection of B cells, deparaffinized sections were blocked in H2O2 and sequentially incubated with a monoclonal rat anti-mouse CD45R / B220 antibody appropriately diluted in 10 % FCS / PBS, a biotinylated goat anti-rat antibody and streptavidin-horse radish peroxidase (all from BD Bioscience, Heidelberg, Germany). Development was performed using 3,3-diaminobenzidine (Sigma, Deisenhofen, Germany) and urea superoxide (Sigma), and hemalum was used to counterstain the slides.

RNA isolation and microarray analysis of pulmonary gene expression

Before and at different time points after aerosol infection with Mtb, weighed lung samples were homogenized in 5 ml of 4 M guanidinium-isothiocyanate buffer and total RNA was extracted by acid phenol extraction.

Affymetrix GeneChips were used for genome-wide expression analysis of the impact of IL-10 overexpression during pulmonary Mtb infection. Tissue from individual mice was processed as biological duplicates (untreated controls and day 25 after infection) and triplicates (day 42 after infection). Per sample, 3 μg total lung RNA was processed using the GeneChip Expression 3’ Amplification One-Cycle Target Labeling Kit according to the manufacterer's instruction. Biotinylated cRNA was hybridized on MOE430A 2.0 GeneChips, that were stained, washed and scanned following standard procedures. Microarray data were deposited in the Gene Expression Omnibus database, the accession number will be made available before publication of the paper. CEL files were processed for global normalization and generation of expression values using the robust multi-array average algorithm (RMA) in the R affy package (http://www.R-project.org). To identify differentially regulated genes, a combination of filtering for absolute (max-min > 50) and relative (max/min > 2) change across all conditions, and statistical testing using ANOVA for the variables “infection” and “genotype” was applied. Correction for multiple testing was done using Benjamini-Hochberg (28). The 4188 probe sets passing the filtering criteria were then subjected to hierarchical clustering and visualization procedures using the Spotfire DecisionSite Functional Genomics software. Data mining of differentially regulated gene lists for enrichment of co-citations with cells and tissues was performed using Genomatix Bibliosphere software (Genomatix, Germany).

RT-PCR

From extracted RNA, cDNA was obtained using murine moloney leukemia virus (MMLV) reverse transcriptase (Invitrogen, Karlsruhe, Germany) and oligo-dT (12−18mer; Sigma) as a primer. Quantitative PCR was performed on a Light Cycler (Roche Diagnostics Corporation, Indianapolis, IN) as previously described (36). Data were analyzed employing the “Fit Points” and “Standard Curve Method” using hprt as housekeeping gene to calculate the level of gene expression normalized for hprt expression. The following primer sets were employed: Hprt: sense 5’-GCA GTA CAG CCC CAA AAT GG-3’, antisense 5’-AAC AAA GTC TGG CCT GTA TCC AA-3’; Tnf: sense 5’-TCT CAT CAG TTC TAT GGC CC-3’, antisense 5’-GGG AGT AGA CAA GGT ACA AC-3’, IL-12p40 (Il12b): sense 5’-CTG GCC AGT ACA CCT GCC AC-3’, antisense 5’-GTG CTT CCA ACG CCA GTT CA-3’, Nos2: sense 5’-AGC TCC TCC CAG GAC CAC AC-3’, antisense 5’-ACG CTG AGT ACC TCA TTG GC-3’, LRG-47 (Irgm1): sense 5’-AGC CGC GAA GAC AAT AAC TG-3’, antisense 5’-CAT TTC CGA TAA GGC TTG G-3’, Arg1: sense 5’-CAG AAG AAT GGA AGA GTC AG-3’, antisense 5’-CAG ATA TGC AGG GAG TCA CC-3’, Mmr: sense 5’-CCA CAG CAT TGA GGA GTT TG-3’, antisense 5’-ACA GCT CAT CAT TTG GCT CA-3’, Ym1: sense 5’-GGG CAT ACC TTT ATC CTG AG-3’, antisense 5’-CCA CTG AAG TCA TCC ATG TC-3’, Fizz: sense 5’-TCC CAG TGA ATA CTG ATG AGA-3’, antisense 5’-CCA CTC TGG ATC TCC CAA GA-3’, Il4ra: sense 5’-TGT GAC CTA CAA GGA ACC CA-3’, antisense 5’-GCA AAA CAA CGG GAT GCA GA-3’.

Preparation of single cell suspensions

Antigen-specific restimulation and flowcytometric analysis, single cell suspensions of mediastinal lymph nodes and lungs were prepared from Mtb-infected mice at different time points. Lymph node cells were isolated by straining through a metal sieve. After depletion of erythrocytes, cells were resuspended in complete Iscoves-modified Dulbeccos medium (IMDM; Invitrogen) supplemented with 10 % FCS (Gibco), 0.05 mM β-mercaptoethanol (Sigma, Deisenhofen, Germany), and penicillin and streptomycin (100 U/ml and 100 μg/ml; Invitrogen), counted and used for further experiments. For preparation of single cell suspensions from lungs, mice were anesthetized and injected intraperitoneally with 150 U Heparin (Ratiopharm, Ulm, Germany). Lungs were perfused through the right ventricle with warm PBS. Once lungs appeared white, they were removed and sectioned. Dissected lung tissue was then incubated in collagenase A (0.7 mg/ml; Roche Diagnostics, Mannheim, Germany) and DNase (30 μg/ml; Sigma) at 37°C for 2 h. Digested lung tissue was gently disrupted by subsequent passage through a 100 μm pore size nylon cell strainer. Recovered lung cells were counted, diluted in IMDM and used for further experiments.

Flowcytometric analysis of surface markers and intracellular cytokines

For flowcytometric analysis of surface markers, cells were washed and incubated with a cocktail containing anti-FcγRIII/II mAb (clone 2.4G2), mouse and rat serum to block non-specific binding to Fc receptors. Cells were then incubated in consecutive steps for 20 min with optimal concentrations of the following antibodies, CD4-APC, CD3-PerCP, CD44-FITC, CD62L-PE, IAq-PE, CD124-PE (IL-4Rα) (all from BD Biosciences) and F4/80-AlexaFluor647 (Caltag; Invitrogen), CD206 (MMR)(Serotec, Düsseldorf, Germany). For detection of intracellular IFNγ, an intracellular cytokine staining kit was employed (BD Biosciences). Briefly, single cell suspensions were prepared at 19 days after infection and 2×106 cells were stimulated with plate-bound anti-CD3/CD28 mAb (clone 2C11 and clone 37/51 at 10 μg/ml, respectively) for 4 h in the presence of GolgiPlug™ (BD Biosciences). Non-specific antibody binding was blocked by incubation with a cocktail containing anti-FcγRIII/II mAb (clone 2.4G2), mouse and rat serum. Cells were washed and incubated with optimal concentrations of anti-CD4-FITC (BD Biosciences). After staining, cells were fixed and permeabilized with Cytofix/Cytoperm™ (BD Biosciences) and intracellularly accumulated IFNγ was stained with a PE-labelled anti-IFNγ mAb (BD Biosciences).

Fluorescence intensity was analysed on a FACSCalibur (BD Biosciences) gating on propidiumiodide-negative macrophages orr lymphocytes identified by FSC-SSC-profile, respectively.

IL-10 release and antigen-specific restimulation of CD4+ T cells

To detect IL-10 release in lymph nodes and lungs, 3×106 cells from single cell suspensions of mediastinal lymph nodes and perfused lungs were cultured for 24 h in complete RPMI 1640 (Gibco) supplemented with 10 % FCS (Gibco), 0.05 mM β-mercaptoethanol (Sigma), and penicillin and streptomycin (100 U/ml and 100 μg/ml; Gibco). Supernatants were collected and frozen at −80°C until production of IL-10 was quantified by ELISA. For measuring antigen-specific production of IFNγ by CD4+ T cells in lymph nodes, single cell suspension of mediastinal lymph nodes were prepared in IMDM from mice 19 days after infection with Mtb. To enrich CD4+ T cells, single cell suspensions from lymph nodes were incubated with magnetic CD4 microbeads (Miltenyi, Bergisch Gladbach, Germany) and separated from other cells on a MACS separation unit (Miltenyi). Separated CD4+ T cells were collected in IMDM, counted and diluted. Purity of enriched CD4+ T cells was >95 % as determined by flow cytometry. For antigen-specific restimulation, 4×105 enriched CD4+ lymph node cells were incubated with 2×105 peritoneal macrophages that were pulsed with 25 μg/ml short-term culture filtrate (ST-CF) from Mtb (a kind gift of Peter Andersen, Copenhagen, Denmark) in IMDM. Resident peritoneal macrophages were obtained one day prior to the experiment by peritoneal lavage of uninfected C57BL/6 mice and incubated overnight in 96 well flat-bottom microplates (Nunc, Naperville, IL) in complete IMDM. After 72 h of restimulation, supernatants were collected and frozen at −80°C until production of IFNγ was quantified by ELISA.

Quantification of IFN-γ and IL-10 by ELISA

To determine cytokine production after pulmonary infection of experimental animals, supernatants were analysed in 3-fold serial dilutions using the sandwich ELISA system OptEia™ (BD Biosciences). After incubation with horseradish peroxidase coupled to avidin and developing with TMB substrate reagent, the absorbance was read on a microplate reader (Sunrise; Tecan, Männedorf, Switzerland). Using a test wavelength of 450nm and a reference wavelength of 630nm samples, were compared to appropriate recombinant cytokine standards. The detection limits for all cytokines were 5 pg/ml.

Arginase activity in BMMϕ and lung homogenates

To determine arginase activity in murine tissue, weighed pieces of organs were homogenized in 100 μl of 0.1 % Triton X-100 (Sigma) containing a protease inhibitor cocktail (Roche). 50 μl of 10 mM MnCl2 (Merck), 50 mM Tris-HCl (Merck) were added to all samples and the enzyme was activated by heating for 10 min at 55°C. Arginine hydrolysis was conducted by incubating 25 μl of the activated lysate with 25 μl of 0.5 M L-arginine (Merck) at 37°C for 60 min. The reaction was stopped with 400 μl of H2SO4 (96%) / H3PO4 (85%) / H2O (1/3/7, v/v/v). As a degree of arginase activity, the urea concentration was measured at 540 nm after addition of 25 μl α-isonitrosopropiophenone (Sigma; dissolved in 100% ethanol) followed by heating at 95°C for 45 min. One unit of arginase activity is defined as the amount of enzyme that catalyzes the formation of 1 μmol urea/min.

Detection of RNI

To detect RNI in uninfected and infected mice, blood was collected at different time points. Utilizing a commercial nitrate reductase kit (Cayman; Axxora, Lörrach, Germany) NO3 was converted into NO2. After adding Griess reagents, the content of NO2 was determined by photometric measurement reading the absorbance at 540 nm on a microplate reader (Sunrise; Tecan) as previously described (27).

IFN-©-induced bacterial growth inhibition in macrophages

To analyse the anti-bacterial activity of macrophages, BMMAn external file that holds a picture, illustration, etc.
Object name is nihms-116656-ig0003.jpg were cultured 48 h before infection with Mtb in DMEM supplemented with 10 % FCS (Biochrom, Berlin, Germany), 2 mM L-glutamine, 1 mM sodium pyruvate, 10 mM HEPES (all from PAA, Cölbe, Germany) in the presence of medium, or incubated with 10 ng/ml IL-4 (BD Bioscience) and 10 ng/ml IL-10 (BD Bioscience). One day before infection, cells were incubated with medium or stimulated with 100 U/ml IFN-© (Peprotech, Hamburg, Germany). Cells were inoculated with Mtb H37Rv at a MOI of 0.5 for 2 h. To determine bacterial uptake at different time points, macrophages were lysed by addition of 0.5 % Triton X100 (Serva, Heidelberg, Germany). Lysates were serially diluted in 0,05 % Tween 80 (Merck), plated on Middlebook 7H10 agar containing 10 % OADC and incubated at 37°C for 19−21 days. Colonies on plates were enumerated and results expressed as log10 CFU per culture.

Statistical analysis

Quantifiable data are expressed as the means of individual determinations and standard deviations. Statistical analysis was performed using the unpaired Student's t test defining different error probabilities (*, p≤0.05; **, p≤0.01; ***, p≤0.001). ANOVA was performed using the Dunnett Multiple Comparison test, correcting for multiple testing, that defines different error probabilities between untreated cells and macrophages that have been incubated with IFNγ (#, p≤0.05; ##, p≤0.01) or IL-4/IL-10/IFNγ (*, p≤0.05; **, p≤0.01) , correcting for multiple testing.

Results

macIL-10tg mice are highly susceptible to Mtb infection

To determine the influence of increased levels of macrophage-derived IL-10 on the outcome of experimental TB, mice overexpressing IL-10 under control of the macrophage-specific CD68 promoter were infected with 100 CFU of Mtb via the aerosol route. Whereas FVB control mice were able to control mycobacterial growth in infected lungs at a plateau level of approx. 6.9 log10 CFU/lung, bacterial loads in IL-10-transgenic littermates steadily increased reaching significantly higher CFU counts 78 days post-infection (Fig. 1a). Mtb-infected FVB wildtype mice survived for more than 250 days (Fig. 1b). In contrast, macIL-10tg animals died significantly earlier, with a mean survival time of approx. 100 days.

Figure 1
macIL-10tg mice are highly susceptible to Mtb infection

Activation of CD4+ T cells is not impaired in Mtb-infected macIL-10tg mice

Priming in lymphoid organs and migration of T lymphocytes to the site of infection is indispensable for the induction of defense-mechanisms against Mtb. In order to evaluate whether T cell activation in macIL-10tg mice was impaired in draining lymph nodes and lung tissue, activated CD4+ T cells were quantified by flow cytometry. After infection with Mtb, comparably increasing relative and absolute numbers of activated CD44highCD62Llow CD4+ T cells were observed in lymph nodes of both FVB and macIL-10tg mice (Fig. 2a and b). Antigen-specific restimulation of CD4+ T cells purified from the draining lymph nodes revealed that T cells of macIL-10tg mice were as capable of producing IFNγ as wildtype littermates (Fig. 2c). In addition, the relative proportion of activated CD44highCD62Llow CD4+ T cells in the lung was also not affected during the course of Mtb infection in macIL-10tg mice (Fig. 2d). However, the absolute amount of activated CD4+ T cells in lungs from macIL-10tg mice was found to be enhanced at day 84 after Mtb infection (Fig. 2e). After polyclonal restimulation, IFNγ-production by CD4+ T cells was comparable in Mtb-infected FVB and macIL-10tg mice (Fig. 2d). Together, macrophage-derived IL-10 did not dramatically affect the induction, migration and function of T effector cells after Mtb infection. The increased infiltration of activated CD4+ T cells into lungs from macIL-10tg mice may reflect an increased inflammatory reaction to the elevated bacterial load at late time points of Mtb infection.

Figure 2
Normal recruitment and activation of T cells in macIL-10tg mice after aerosol infection with Mtb

The expression of NOS2 and LRG-47 (Irgm1) is not impaired in macIL-10tg mice after Mtb-infection

IFNγ-dependent activation of macrophages at the site of infection is key to the induction of the effector molecules NOS2 and LRG-47 (4, 5) and IL-10 has been previously described to affect anti-microbial effector mechanisms (29, 30). Since the expression of T cell-derived IFNγ was not affected in Mtb-infected macIL-10tg mice, downstream effector mechanisms could have been directly impaired by the macrophage-specific overexpression of IL-10. Quantitative real time PCR revealed that during Mtb infection transcripts for Nos2 were increasingly induced in lungs from both FVB and macIL-10tg mice to the same extent (Fig. 3a). In fact, at day 90 post-infection, Nos2 gene expression was found to be even higher in transgenic animals. It should be noted that IL-10 has been shown to induce Nos2 expression in some settings suggesting that Nos2 is not a canonical target of the IL-10 anti-inflammatory response (31). The kinetics of gene expression of Lrg-47 (Irgm1) was comparable in the lungs of both FVB and macIL-10tg mice peaking on day 21 of Mtb infection (Fig 3b). Six weeks after infection, immunohistochemical detection of NOS2 in lung sections verified these findings on the protein level showing no differences in NOS2-expression between FVB and macIL-10tg mice (Fig. 3c).

Figure 3
Efficient induction of IFNγ-dependent effector mechanisms in Mtb-infected macIL-10tg mice

Macrophage-derived IL-10 specifically suppresses IL-12p40 in infected tissue but not in draining lymph nodes

So far, the increased susceptibility of macIL-10tg mice to experimental TB could neither be attributed to an impaired function of IFNγ-producing T cells nor to defective IFNγ-dependent downstream mechanisms in macrophages. IL-10 specifically suppresses the production of pro-inflammatory cytokines in activated macrophages and dendritic cells (9, 32). To evaluate the suppressive effect of macrophage-derived IL-10 on anti-TB effector cytokines during the course of infection with Mtb, we compared the expression of TNF (produced by T cells and macrophages/dendritic cells) and IL-12p40 (produced by macrophages/dendritic cells) in the lungs of FVB wildtype and IL-10tg mice. Until day 90 after infection, increasing amounts of Tnf transcripts were found in the lungs of FVB mice (Fig. 4a). In the lungs of macIL-10tg mice, however, gene expression was found to be even higher on days 49 and 90 post-infection. In contrast, 49 and 90 days after Mtb infection, gene expression of IL-12p40 (Il12b) was found to be significantly reduced in lungs from macIL-10tg mice when compared to FVB mice (Fig. 4b).

Figure 4
Differential production of IL-10 specifically suppresses IL-12p40 in infected tissue but not in draining lymph nodes

After Mtb infection, IL-12 is essential for driving protective TH1 immune responses (33). In lymphoid organs, IL-10 inhibits IL-12-driven TH1 development, whereas it has no suppressive effect on already differentiated TH1 cells in infected tissue (34). Because Mtb-infected macIL-10tg mice displayed a normal TH1 development, we speculated that the magnitude of transgenic IL-10 expression would be different in draining lymph nodes and lung tissue. In contrast to dendritic cells, only few macrophages are present in lymph nodes in experimental TB (35). Accordingly, we found only low levels of IL-10 in lymph nodes from macIL-10tg mice (Fig. 4c). In contrast, a great amount of IL-10 was secreted in lung tissue from macIL-10tg animals. In FVB mice, IL-10 was below detection limit in either organ (Fig. 4c). In line with the low expression of transgenic IL-10 in the lymph nodes of Mtb-infected macIL-10tg mice, IL-12p40 expression was not affected. In contrast, elevated levels of transgenic IL-10 in lung tissue led to reduced expression of IL-12p40 (Fig. 4d). Taken together, IL-10 secretion by macrophages does not seem to have an overt effect on TH1 differentiation and the expression of TH1 cell effector mechanisms. Macrophage-derived IL-10 rather appears to regulate distinct macrophage functions such as cytokine secretion at the site of infection.

Impact of Mtb infection on pulmonary gene expression in wildtype and macIL-10tg mice

To investigate how macrophage-specific overexpression of IL-10 shapes the host response to Mtb at the transcriptome level, genome-wide expression analysis was performed on tissue RNA isolated from the lungs of FVB and macIL-10tg mice at baseline as well as 25 and 42 days after infection. Excluding variability for the infection itself, only 219 probe sets were different between FVB and macIL-10tg , indicating a comparatively small effect of IL-10 on the transcriptional changes. The effect of IL-10 on the number of up- and down-regulated genes is summarized in Fig. 5a. Prior to infection, only 36 probesets were upregulated in lungs from macIL-10tg mice compared to FVB animals (data not shown). These included some known IL-10-induced genes (Msr1, Ccr2, Ccr5, Fcgr2b, Saa3). Only four probesets, all detecting Igg, gave significantly higher signals in lungs from FVB mice. After infection, at the early time point d25, of all probesets induced more than threefold in either lung RNA from wildtype or macIL-10tg mice, only one probeset (C3ar1) had significantly increased expression in macIL-10tg mice, whereas Igh-VJ588 was higher in FVB control animals. Of the 970 probe sets induced by Mtb 42 days after infection, 158 showed higher expression in macIL-10tg, whereas 68 were significantly higher in lungs from wildtype mice. Therefore, the majority of IL-10 effects was apparent at the later stages of infection.

Figure 5
Pulmonary gene expression in wildtype and macIL-10tg mice

Hierarchical clustering of the probe sets regulated by IL-10 (Fig. 5b, data are listed in Supplementary Table 1) revealed groups of genes overexpressed in the lungs of macIL-10tg mice already under basal conditions (cluster A) or post-infection (cluster B). These clusters contained known target genes of IL-10 in macrophages like Socs3, Bcl3, Saa3 and Il1rn, consistent with previous observations (31). However, many chemokines (e.g. Ccl2, Ccl7) and cytokines (Il1b, Il6) were also expressed at higher levels in the lungs of macIL-10tg mice compared to wildtype animals, indicating that the inhibitory effect of IL-10 on proinflammatory gene expression is likely affected by the increased bacterial load in macIL-10tg mice.

Data mining: changes in cellular composition

The presence of various transcripts encoding cell type-specfic surface proteins, such as the dendritic cell marker Cd207 in cluster C and the monocyte/macrophage marker Msr1 in cluster B, suggested an impact of IL-10 on the infection-induced changes in the cellular composition of the lung tissue. We used a literature-based data mining tool, Genomatix Bibliosphere, to search for overrepresentation of anatomical terms in lists of genes upregulated in macIL-10tg or wildtype mice after Mtb infection (Fig. 6a). While transcriptional evidence for NK cells, dendritic cells and T lymphocytes was similar in both genotypes, in the lungs of macIL-10tg mice a strong enrichment for probe sets associated with macrophages was evident. In contrast, probe sets upregulated to higher levels in FVB lungs at d42 were connected to B lymphocytes. Immunohistological analysis also revealed a moderately reduced infiltration of B cells in lungs from macIL-10tg mice (Supplementary Figure 1). Together, IL-10 appears to regulate leukocyte subset migration to the lung, or local proliferation of the cells, during Mtb infection.

Figure 6
Signs of alternative macrophage activation in the lung transcriptome of macIL-10tg mice after Mtb infection

Signs of alternative macrophage activation in the lung transcriptome after Mtb infection

Among the group of genes induced to high levels in infected macIL-10tg mice was Arg1 (Fig. 6b), encoding the enzyme arginase-1, whose extrahepatic expression is typically associated with IL-4/IL-13-induced alternative macrophage activation indicating that after Mtb infection IL-10 may promote the development of alternatively activated macrophages. While Il4 and Il13 mRNA was not detectably expressed in the lung dataset, small amounts of IL-4 or IL-13 could promote alternative activation of lung macrophages in macIL-10tg mice. IL-10 may enhance the sensitivity to IL-4 because it increases IL-4 receptor-alpha (Il4ra) expression on macrophages in vitro (31), an effect that was also observed in the lung dataset after Mtb infection (Fig. 6b). In addition to arginase-1, many other markers have been described to define IL-4 receptor-alpha (Rα)-mediated alternatively activated macrophages especially during pulmonary inflammation such as Fizz1, various chitinases and the macrophage mannose receptor (MMR) (36). Among these genes, only Fizz1 (encoded by Retlna) and the chitinase Chi3l1 were clearly expressed at higher levels in macIL-10tg lungs (Fig. 6b), whereas the chitinases Ym1 (=Chi3l3) and Ym2 (=Chi3l4) as well as the Mmr (encoded by Mrc1) were downregulated after infection to similar levels in both genotypes. The differential induction of markers for alternatively activated macrophages in Mtb-infected macIL-10tg mice reflects also some opposite biological effects of IL-10 to IL-4 and IL-13 e.g. the regulation of MMR expression and function (37). In contrast to this rather inhibitory effect, IL-10 has been clearly shown to contribute to alternative macrophage activation during Toll-like receptor ligation by a strong synergistic induction of Arginase-1 (31). Together, our genome wide expression analysis revealed that after infection with Mtb, macrophage-derived IL-10 induces several features of alternatively activated macrophages.

After Mtb-infection, macIL-10tg mice develop alternatively activated macrophages

To verify our findings revealed by genome-wide expression analysis, we next performed qRT-PCR analysis to test the model that macrophage-derived IL-10 promotes alternative macrophage activation after Mtb infection (Fig. 7a). Six weeks after infection, we found significantly elevated gene expression of Fizz1 and Arg1. In contrast, transcripts for Mmr and the chitinase Ym1 were not elevated. In whole tissue, Il4ra gene expression in macIL-10tg mice was elevated but not significantly different from gene expression in lungs from FVB wildtype mice. To determine the activation state of macrophages in Mtb-infected macIL-10tg mice, we analysed macrophages from perfused lungs by flow cytometry. Six weeks after infection IAq, CD80, CD86, and the MMR were expressed to the same extent on PI-negative F4/80-positive cells from FVB and macIL-10tg mice (Fig. 7b). Whereas only a subpopulation of macrophages from infected FVB mice expressed the IL-4Rα, all macrophages from macIL-10tg mice were found to be positive for this receptor subunit. Together, we found that after Mtb infection IL-10 secretion by macrophages induces an alternatively activated program characterized by an enhanced expression of Fizz1, Arg1 and the Il4ra.

Figure 7
Enhanced alternative macrophage activation in lungs from Mtb-infected macIL-10tg mice

In Mtb-infected macIL-10tg mice, increased arginase-1 activity is concomitant with reduced production of RNI

Classical macrophage activation plays an important role in combating infection with Mtb through IFNγ-induced expression of effector molecules such as NOS2-dependent RNI (4). This induction may be counter-regulated in alternatively activated macrophages. Because in alternatively activated macrophages arginase-1 hydrolyses L-arginine to urea and L-ornithine this pathway is also discussed to regulate RNI production in macrophages through depletion of L-arginine as the substrate for NOS2 (38, 39). Therefore, we speculated that in macIL-10tg mice an increased arginase-1 activity modulates the production of RNI thereby affecting effector mechanisms against Mtb usually exerted by classically activated macrophages. A kinetic quantification of gene expression revealed that Arg1 is not induced in lungs from FVB mice during the course of Mtb-infection (Fig. 8a). In contrast, Arg1 expression in macIL-10tg mice was found to be significantly induced during the late phase of Mtb infection. Accordingly, arginase activity in lungs from macIL-10tg mice was found to be elevated already 49 days post-infection (Fig. 8c). In contrast, arginase activity was detectable in the lungs of FVB mice but did not increase after infection (Fig. 8b). Concomitant with the increased arginase-1 activity in infected macIL-10tg mice, RNI were only moderately produced in these animals (Fig. 8c). In distinction, significantly increasing amounts of RNI were found in sera from Mtb-infected FVB mice (Fig. 8c). Hence, the increased susceptibilty in macIL-10tg mice after infection with Mtb appeared to be caused by an elevated induction of arginase-1 in alternatively activated macrophages which in turn led to an inefficient production of RNI. To examine whether IL-10-induced arginase-1 expression in macrophages diminishes anti-mycobacterial effector mechanisms in macrophages, we performed a Mtb growth inhibition assay in arginase-1-deficient BMMϕ (Fig. 8d). Incubation of BMMϕ from Tie2cre-neg Arg-1flox/flox arginase-1-competent and Tie2cre-pos Arg-1flox/flox arginase-1-deficient mice lead to a significant reduction of mycobacterial growth 48 and 72 h after infection with Mtb when compared to infected macrophages that have not been activated with IFNγ. Pre-incubation with IL-4 and IL-10, however, diminished IFNγ-dependent mycobacterial growth inhibition in arginase-1-competent BMMϕ. In contrast, IL-4/IL-10 treatment of IFNγ-activated arginase-1-deficient macrophages did not lead to reduced anti-mycobacterial effector mechanisms indicating that induction of arginase-1 in macrophages reduces the capability of controling Mtb growth.

Figure 8
IL-10-dependent arginase-1 induction diminished anti-mycobacterial effector mechanisms

macIL-10tg mice control bacterial growth after M. avium infection

To test our hypothesis that macrophage-derived IL-10 mostly subverts NOS2-dependent effector mechanisms, we infected macIL-10tg mice aerogenically with M. avium, a pathogen that is insensitive to NOS2-derived RNI production (6, 40), and determined bacterial loads in different organs 105 days after infection (Fig. 9). Bacterial loads in macIL-10tg mice were found to be only moderately increased in lung and liver, and comparable to FVB mice in spleens. However, infection of NOS2−/− mice with M. avium revealed that bacterial loads have been described to rather decreased in the absence of NOS2 (40) corroborating the contention that after infection with RNI-insensitive mycobacteria the suppressive effect of nitric oxide on T cells appears (6). Therefore, the inability of macIL-10tg mice to efficiently control bacterial growth after infection with RNI-sensitive and to some extend also - insensitive mycobacteria indicates that autocrine IL-10 operates partially by reducing RNI production via arginase-1 induction.

Figure 9
macIL-10tg mice control bacterial growth after M. avium infection

DISCUSSION

TB is a systemic disease that becomes manifest most prominently in the lung (24). Progressive primary TB occurs when the initial inflammatory focus is unable to contain mycobacterial replication and the disease spreads to other parts of the lung. Post-primary disease develops when a lesion containing a previously “dormant”, i.e. growth-arrested, organism resumes growth after a period of clinical latency. This organism may have been implanted years before during a primary infection that was successfully contained by a protective TH1 type immune response. Reactivation is often a consequence of a perturbed immune status of the host, although the cause of deregulation may be multifactorial.

Elevated levels of the TH2 cytokine IL-10 were detected in individuals with active tuberculosis (18, 19). Importantly, macrophages rather than T cells were reported to be the major source of IL-10 in these patients (18). However, whether and how macrophage-derived IL-10 promotes exacerbation of primary infection or reactivation of chronic, latent infection is not clear. Our study revealed that in macIL-10tg mice an increased production of IL-10 by macrophages resulted in enhanced Mtb replication particularly during the chronic phase of infection, and thus bears some resemblance to reactivation TB in humans.

Humans infected with Mtb typically have a strong DTH response, as measured by the PPD skin test (24). This holds also true for patients suffering from post-primary TB. Thus, despite an apparently adequate initial differentiation of cell-mediated immune responses, Mtb is capable of persisting and can even resume replication within macrophages. In the draining lymph nodes of Mtb-infected macIL-10tg mice T cells efficiently differentiated into TH1 cells and migrated to the site of infection. In spite of the presence of macrophage-derived IL-10 in the lungs of infected transgenic mice, TH1 cells efficiently expressed effector functions and secreted sufficient IFNγ to induce a classical macrophage activation characterized by expression of NOS2 and LRG-47. However, bacteria survived and successfully proliferated within IFNγ-activated IL-10tg macrophages. It appears, therefore, that during experimental TB macrophage-derived IL-10 does not affect initiation and maintenance of TH1 immune responses but specifically acts on macrophage functions in a partially dominant manner over IFNγ at the functional level.

It is important to note that overexpression of IL-10 specifically in T cells resulted in completely different immunosuppressive mechanisms after Mtb infection (22). tIL-10tg mice failed to efficiently prime naïve CD4+ T cells in draining lymph nodes resulting in decreased numbers of activated T cells in the blood circulation and lung tissue; this defective TH1 response eventually led to an increased bacterial burden, due to a failure of classical macrophage activation. In contrast, IL-10 expression in macrophages at the site of infection induces an alternative activation program specifically in macrophages that counteracts concomitant classical macrophage activation. Since T cell-mediated immune responses remain largely unaffected (as is the case in human post-primary TB), the outcome of experimental TB in macIL-10tg mice may therefore better reflect the situation in patients with reactivating TB.

We could link the increased susceptibility of Mtb-infected macIL-10tg mice neither to an impaired function of IFNγ-producing T cells nor to defective IFNγ-dependent downstream mechanisms in macrophages. Transcriptome analysis revealed a strong enrichment for probe sets associated with macrophage function in the lungs of Mtb-infected macIL-10tg mice. IL-10 has previously been shown to act primarily on activated macrophages, where IL-10 receptor (IL-10R) expression is highest. The IL-10R activates STAT3 and loss of this transcription factor in macrophages mimics loss of IL-10 itself (41). Hence, because STAT3 in myeloid cells is both necessary and sufficient for the effects of IL-10 macrophages are major targets of IL-10 in vivo (41-44). On a functional level, IL-10 has been shown to negatively regulate macrophage function in a variety of experimental systems (17, 29, 30, 45). In vitro, IL-10 antagonizes the IFNγ-dependent induction of NOS2 (29, 30). Our finding that macIL-10tg mice fail to efficiently control bacterial growth especially after infection with RNI-sensitive mycobacteria corroborates our contention that the mode of action of autocrine IL-10 proceeds minly via arginase-1 mediated reduction of RNI production in macrophages. However, we found NOS2 normally expressed in Mtb-infected macIL-10tg mice whereas the production of RNI was reduced during the course of infection. Hence, other pathways must be affected in macrophages of macIl-10tg mice that lead to an impaired expression of effector molecules such as RNI.

Among the group of genes induced to high levels in Mtb-infected macIL-10tg mice some were associated with alternative macrophage activation such as Il4ra, Fizz1 and Arg1. (36). Alternative macrophage activation is typically induced by IL-4Rα ligation. While Il4 and Il13 mRNA was not detectably expressed in the lung dataset, small amounts of IL-4 may still drive alternative activation of lung macrophages in macIL-10tg mice. IL-10 may enhance the sensitivity to IL-4 because it increases IL-4 receptor expression on macrophages in vitro (31), an effect that was also observed in the lung dataset after Mtb infection. The differential induction of markers for alternatively activated macrophages in Mtb-infected macIL-10tg mice reflects also some opposite biological effects of IL-10 to IL-4 and IL-13 e.g. the regulation of MMR expression and function (37). In contrast to this rather inhibitory effect, IL-10 has been clearly shown to contribute to alternative macrophage activation during Toll-like receptor ligation by a strong synergistic induction of Arginase-1 (31). Hence, during experimental TB Arg1 expression may be directly induced by IL-10 or indirectly by IL-10-dependent upregulation of the high affinity IL-4Rα. Alternative activation of macrophages via the IL-4Rα has been shown to differentially regulate protective and immunopathological immune responses (36). Importantly, analysis of macrophage-specifc IL-4Rα-deficient mice clearly demonstrated immunomodulation by macrophages to be a central regulatory mechanism during inflammatory immune responses in vivo (46). Because alternative macrophage activation reduces RNI production (39, 47, 48) and pro-inflammatory cytokine release (49), protective (38, 50, 51) and pathological (49) immune responses are significantly regulated by this type of macrophages.

In the context of TB and alternatively activated macrophages one genome-wide expression analysis in IL-4 stimulated murine bone marrow-derived macrophages infected with Mtb has been published so far (50). A specific re-analysis of our lung transcriptome data for differences in the expression of the 15 most highly increased genes in Mtb-infected IL-4-stimulated macrophages revealed that 5 genes were expressed at significantly higher levels in macIL-10tg lungs than in FVB mice after infection (Fcrg2b, Fn1, Cish, Ccl9, Mrc1) and Cdh1 was increased under basal conditions in macIL-10tg lungs (data not shown). Mmp12 (encoding matrix metalloproteinase-12, MMP-12) and Tfr (encoding the transferrin receptor, TfR) were found to be significantly upregulated in Mtb-infected alternatively activated macrophages in vitro (50). The induction of the TfR appears to be of major importance in the context of experimental TB because intracellular Mtb exploit the transferrin-transferring receptor complex for iron utilization (52). However, neither our genome-wide expression analysis nor quantitative RT-PCR revealed a differential regulation of Tfr in Mtb-infected macIL-10tg mice in vivo (data not shown). Additionally, Kahnert and colleagues suggested MMP-12 induced in alternatively activated macrophages to be involved in the pathogenesis of TB (50). Though our genome-wide expression analysis in Mtb-infected macIL-10tg mice revealed an increased expression of Mmp12 in macIL-10tg mice at later time points of infection, the difference was not significant (data not shown). Moreover, quantitative RT-PCR of Mmp12 did not confirm a difference between wildtype and macIL-10tg mice (data not shown). Together, genome-wide expression analysis in Mtb-infected and IL-4-induced alternatively activated macrophages in vitro and in Mtb-infected macIL-10tg mice in vivo revealed an overlapping set of regulated genes, consistent with our interpretation that IL-10 supports a macrophage phenotype in vivo that is phenotypically related to alternatively activated macrophages.

Until recently little was known about the impact of alternative macrophage activation and arginase-1 on the outcome of Mtb infection. Classical macrophage activation plays a central role in combating infection with Mtb through IFNγ-induced expression of effector molecules such as the NOS2-dependent production of RNI (4, 53). Importantly, inhibition of endogenous NOS2 reactivates latent infection in Mtb-infected mice, indicating that NOS2-dependent mechanisms in macrophages are crucial for the control of Mtb persisting in immunocompetent hosts (54). The production of RNI might be counter-regulated by IL-4Rα- and/or IL-10-dependent mechanisms, leading to arginase-1 expressing alternatively activated macrophages. In fact, RNI production in Mtb-infected alternatively activated macrophages was found to be reduced (50). In line with these findings we here show the induction of arginase-1 in macrophages subverts IFNγ-induced anti-mycobacterial effector mechanisms in macrophages. Since NOS2 shares L-arginine as a substrate with arginase-1, substrate depletion by either enzyme is a key regulatory mechanism in macrophages and differential expression of NOS2 and arginase-1 is important for regulating macrophage effector functions (39, 48). Very recently, El Kasmi et al. showed that specific deletion of arginase-1 in macrophages reduced lung bacterial loads during Mtb infection supporting our contention that arginase-1 induction in macrophages undermines NOS2-dependent effector mechanisms against Mtb by depletion of the common substrate L-arginine (26). In addition, arginase-dependent production of polyamines were shown to promote elevated growth of Leishmania major in macrophages (51) and may also be beneficial for the proliferation of Mtb. Importantly, in human pulmonary TB, high production of IL-10 also parallels arginase activity in peripheral-blood mononuclear-cells (55). Hence, elevated IL-10-dependent arginase activity during the chronic phase of infection may promote recrudescence of Mtb growth. We do not exclude that macrophage-derived IL-10 suppresses other anti-mycobacterial effector mechanisms in addition to regulating RNI synthesis. In contrast to infection with Mtb, macIL-10tg mice were indeed able to control bacterial growth after infection with M. avium, which has been shown to be insensitive to the effects of RNI (6, 40). However, because bacterial loads have been described to be further reduced after infection with M. avium in the complete absence of RNI in NOS2−/− mice, it appears that although autocrine IL-10 subverts RNI synthesis in macrophages other suppressive mechanisms may also be induced by IL-10.

We conclude that during Mtb infection macrophage-derived IL-10 drives reactivation during the chronic stage of the disease by acting primarily at the level of the macrophage. Macrophage-derived IL-10 appears to override IFNγ-dependent classical macrophage activation and effector mechanisms against Mtb by inducing an alternatively activated phenotype. Specifically, Arg1 expression in these macrophages may provide better growth conditions for Mtb. TH2 cytokines that potently drive alternative macrophage activation have been associated with the development of post-primary TB in patients (7, 56). Thus, reactivating TB may, in part, be mediated by a TH2 type immune reaction characterized by an alternative activation state of macrophages that eventually subverts protective immune mechanisms. It is possible that the identification of an increased type 2 cytokine immune response may identify infected individuals at risk to reactivate a latent Mtb infection. Additionally, prophylactic treatment of these individuals with immunomodulating drugs aimed at inhibiting the production of type 2 cytokines or downstream immune mechanisms may prevent or ameliorate reactivation TB.

Supplementary Material

1

Supplementary table 1. Private set of genes regulated in lungs of FVB and macIL-10tg before and after infection with Mtba

Acknowledgements

The authors thank Alexandra Hölscher, Tanja Sonntag, Susanne Metken and Manfred Richter for excellent technical assistance; Ilka Monath, Sven Mohr and Claus Möller for organising the animal facility and taking care of the mice at the Research Center Borstel; Angela Servatius for management of the macIL-10tg colony and processing the microarray samples at the Institute of Medical Microbiology, Immunology and Hygiene, Technical University Munich; Bianca Schneider for help with the Mtb growth inhibition assay.

Footnotes

1Supported by a research grant (“Host defence against infections”) from the Medical University of Lübeck to C.H., BMBF grants NIES05T22 to S.E., 01KI0784 to S.E. and C.H., and NGFN-2 FKZ 01GS0402 to R.L., the Deutsche Forschungsgemeinschaft La 1262/3−1 to R.L., and NIH grant AI062921 to P.J.M..

References

1. Kaufmann SH. Tuberculosis: back on the immunologists’ agenda. Immunity. 2006;24:351–357. [PubMed]
2. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J. Exp.Med. 1993;178:2243–2247. [PMC free article] [PubMed]
3. Flynn JL, Goldstein MM, Chan J, Triebold KJ, Pfeffer K, Lowenstein CJ, Schreiber R, Mak TW, Bloom BR. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity. 1995;2:561–572. [PubMed]
4. MacMicking JD, North RJ, LaCourse R, Mudgett JS, Shah SK, Nathan CF. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. U.S.A. 1997;94:5243–5248. [PubMed]
5. MacMicking JD, Taylor GA, McKinney JD. Immune control of tuberculosis by IFN-gamma-inducible LRG-47. Science. 2003;302:654–659. [PubMed]
6. Ehlers S, Benini J, Held HD, Roeck C, Alber G, Uhlig S. αβ T Cell Receptor-positive Cells and Interferon-γ, but not Inducible Nitric Oxide Synthase, Are Critical for Granuloma Necrosis in a Mouse Model of Mycobacteria-induced Pulmonary Immunopathology. J .Exp. Med. 2001;194:1847–1859. [PMC free article] [PubMed]
7. Rook GA. Th2 cytokines in susceptibility to tuberculosis. Curr. Mol. Med. 2007;7:327–337. [PubMed]
8. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 2001;19:683–765. [PubMed]
9. Lang R. Tuning of macrophage responses by STAT3-inducing cytokines: molecular mechanisms and consequences in infection. Immunobiology. 2005;210:63–76. [PubMed]
10. Murray PJ. Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response. Curr. Opin. Pharmacol. 2006;6:379–386. [PubMed]
11. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 1993;178:1041–1048. [PMC free article] [PubMed]
12. Macatonia SE, Doherty TM, Knight SC, O'Garra A. Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-gamma production. J. Immunol. 1993;150:3755–3765. [PubMed]
13. Berg DJ, Kuhn R, Rajewsky K, Muller W, Menon S, Davidson N, Grunig G, Rennick D. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J. Clin. Invest. 1995;96:2339–2347. [PMC free article] [PubMed]
14. Kühn R, Lohler J, Rennick D, Rajewsky K, Müller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 1993;75:263–274. [PubMed]
15. Dai WJ, Köhler G, Brombacher F. Both innate and acquired immunity to Listeria monocytogenes infection are increased in IL-10-deficient mice. J. Immunol. 1997;158:2259–2267. [PubMed]
16. Kane MM, Mosser DM. The role of IL-10 in promoting disease progression in leishmaniasis. J. Immunol. 2001;166:1141–1147. [PubMed]
17. Hölscher C, Mohrs M, Dai WJ, Köhler G, Ryffel B, Schaub GA, Mossmann H, Brombacher F. Tumor necrosis factor alpha-mediated toxic shock in Trypanosoma cruzi-infected interleukin 10-deficient mice. Infect. Immun. 2000;68:4075–4083. [PMC free article] [PubMed]
18. Barnes PF, Lu S, Abrams JS, Wang E, Yamamura M, Modlin RL. Cytokine production at the site of disease in human tuberculosis. Infect. Immun. 1993;61:3482–3489. [PMC free article] [PubMed]
19. Verbon A, Juffermans N, Van Deventer SJ, Speelman P, Van Deutekom H, Van Der Poll T. Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment. Clin. Exp. Immunol. 1999;115:110–113. [PubMed]
20. North RJ. Mice incapable of making IL-4 or IL-10 display normal resistance to infection with Mycobacterium tuberculosis. Clin. Exp. Immunol. 1998;113:55–58. [PubMed]
21. Murray PJ, Young RA. Increased antimycobacterial immunity in interleukin-10-deficient mice. Infect. Immun. 1999;67:3087–3095. [PMC free article] [PubMed]
22. Turner J, Gonzalez-Juarrero M, Ellis DL, Basaraba RJ, Kipnis A, Orme IM, Cooper AM. In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice. J. Immunol. 2002;169:6343–6351. [PubMed]
23. Murray PJ, Wang L, Onufryk C, Tepper RI, Young RA. T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. J. Immunol. 1997;158:315–321. [PubMed]
24. Ehlers S, Hölscher C. DTH-associated pathology. In: Kaufmann SH, editor. Microbiology and microbial infections. Arnold Publsihing; London, U.K.: 2005. pp. 705–720.
25. Lang R, Rutschman RL, Greaves DR, Murray PJ. Autocrine Deactivation of Macrophages in Transgenic Mice Constitutively Overexpressing IL-10 Under Control of the Human CD68 Promoter. J. Immunol. 2002;168:3402–3411. [PubMed]
26. El Kasmi KC, Qualls JE, Pesce JT, Smith AM, Thompson RW, Henao-Tamayo M, Basaraba RJ, König T, Schleicher U, Koo MS, Kaplan G, Fitzgerald KA, Tuomanen EI, Orme IM, Kanneganti TD, Bogdan C, Wynn TA, Murray PJ. Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nat. Immunol. 2008;9:1399–1406. [PMC free article] [PubMed]
27. Hölscher C, Köhler G, Müller U, Mossmann H, Schaub GA, Brombacher F. Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase. Infect. Immun. 1998;66:1208–1215. [PMC free article] [PubMed]
28. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. Roy. Stat. Soc. 1995;57:289–300.
29. Flesch IE, Hess JH, Oswald IP, Kaufmann SH. Growth inhibition of Mycobacterium bovis by IFN-gamma stimulated macrophages: regulation by endogenous tumor necrosis factor-alpha and by IL-10. Int. Immunol. 1994;6:693–700. [PubMed]
30. Gazzinelli RT, Oswald IP, James SL, Sher A. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. J. Immunol. 1992;148:1792–1796. [PubMed]
31. Lang R, Patel D, Morris JJ, Rutschman RL, Murray PJ. Shaping Gene Expression in Activated and Resting Primary Macrophages by IL-10. J. Immunol. 2002;169:2253–2263. [PubMed]
32. Bogdan C, Paik J, Vodovotz Y, Nathan C. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10. J. Biol. Chem. 1992;267:23301–23308. [PubMed]
33. Cooper AM, Magram J, Ferrante J, Orme IM. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J. Exp. Med. 1997;186:39–45. [PMC free article] [PubMed]
34. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, O'Garra A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 1991;146:3444–3451. [PubMed]
35. Bhatt K, Hickman SP, Salgame P. Cutting edge: a new approach to modeling early lung immunity in murine tuberculosis. J. Immunol. 2004;172:2748–2751. [PubMed]
36. Gordon S. Alternative activation of macrophages. Nat. Rev. Immunol. 2003;3:23–35. [PubMed]
37. Montaner LJ, da Silva RP, Sun J, Sutterwala S, Hollinshead M, Vaux D, Gordon S. Type 1 and type 2 cytokine regulation of macrophage endocytosis: differential activation by IL-4/IL-13 as opposed to IFN-gamma or IL-10. J. Immunol. 1999;162:4606–4613. [PubMed]
38. Hölscher C, Arendse B, Schwegmann A, Myburgh E, Brombacher F. Impairment of Alternative Macrophage Activation Delays Cutaneous Leishmaniasis in Nonhealing BALB/c Mice. J. Immunol. 2006;176:1115–1121. [PubMed]
39. Rutschman R, Lang R, Hesse M, Ihle JN, Wynn TA, Murray PJ. Cutting edge: Stat6-dependent substrate depletion regulates nitric oxide production. J. Immunol. 2001;166:2173–2177. [PubMed]
40. Gomes MS, Florido M, Pais TF, Appelberg R. Improved clearance of Mycobacterium avium upon disruption of the inducible nitric oxide synthase gene. J. Immunol. 1999;162:6734–6739. [PubMed]
41. Takeda K, Clausen BE, Kaisho T, Tsujimura T, Terada N, Förster I, Akira S. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity. 1999;10:39–49. [PubMed]
42. Williams LM, Ricchetti G, Sarma U, Smallie T, Foxwell BM. Interleukin-10 suppression of myeloid cell activation--a continuing puzzle. Immunology. 2004;113:281–292. [PubMed]
43. Williams L, Bradley L, Smith A, Foxwell B. Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages. J. Immunol. 2004;172:567–576. [PubMed]
44. El Kasmi KC, Holst J, Coffre M, Mielke L, de Pauw A, Lhocine N, Smith AM, Rutschman R, Kaushal D, Shen Y, Suda T, Donnelly RP, Myers MG, Jr., Alexander W, Vignali DA, Watowich SS, Ernst M, Hilton DJ, Murray PJ. General nature of the STAT3-activated anti-inflammatory response. J. Immunol. 2006;177:7880–7888. [PubMed]
45. Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin 10. J. Exp. Med. 1991;174:1549–1555. [PMC free article] [PubMed]
46. Herbert DR, Hölscher C, Mohrs M, Arendse B, Schwegmann A, Radwanska M, Leeto M, Kirsch R, Hall P, Mossmann H, Claussen B, Förster I, Brombacher F. Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity. 2004;20:623–635. [PubMed]
47. Hesse M, Modolell M, La Flamme AC, Schito M, Fuentes JM, Cheever AW, Pearce EJ, Wynn TA. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. J. Immunol. 2001;167:6533–6544. [PubMed]
48. Munder M, Eichmann K, Modolell M. Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype. J. Immunol. 1998;160:5347–5354. [PubMed]
49. Herbert DBR, Orekov T, Perkins C, Rothenberg ME, Finkelman FD. IL-4R α Expression by Bone Marrow-Derived Cells Is Necessary and Sufficient for Host Protection against Acute Schistosomiasis. J. Immunol. 2008;180:4948–4955. [PMC free article] [PubMed]
50. Kahnert A, Seiler P, Stein M, Bandermann S, Hahnke K, Mollenkopf H, Kaufmann SH. Alternative activation deprives macrophages of a coordinated defense program to Mycobacterium tuberculosis. Eur. J. Immunol. 2006;36:631–647. [PubMed]
51. Kropf P, Fuentes JM, Fahnrich E, Arpa L, Herath S, Weber V, Soler G, Celada A, Modolell M, Müller I. Arginase and polyamine synthesis are key factors in the regulation of experimental leishmaniasis in vivo. FASEB J. 2005;19:1000–1002. [PubMed]
52. Schaible UE, Collins HL, Priem F, Kaufmann SH. Correction of the iron overload defect in beta-2-microglobulin knockout mice by lactoferrin abolishes their increased susceptibility to tuberculosis. J. Exp. Med. 2002;196:1507–1513. [PMC free article] [PubMed]
53. Flesch IE, Kaufmann SH. Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates. Infect. Immun. 1991;59:3213–3218. [PMC free article] [PubMed]
54. Chan J, Tanaka K, Carroll D, Flynn J, Bloom BR. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect. Immun. 1995;63:736–740. [PMC free article] [PubMed]
55. Zea AH, Culotta KS, Ali J, Mason C, Park HJ, Zabaleta J, Garcia LF, Ochoa AC. Decreased expression of CD3zeta and nuclear transcription factor kappa B in patients with pulmonary tuberculosis: potential mechanisms and reversibility with treatment. J. Infect. Dis. 2006;194:1385–1393. [PubMed]
56. Seah GT, Scott GM, Rook GA. Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis. J. Infect. Dis. 2000;181:385–389. [PubMed]